Stock Analysis

Totally Full Year 2024 Earnings: UK£0.016 loss per share (vs UK£0.009 profit in FY 2023)

AIM:TLY
Source: Shutterstock

Totally (LON:TLY) Full Year 2024 Results

Key Financial Results

  • Revenue: UK£106.7m (down 21% from FY 2023).
  • Net loss: UK£3.13m (down by 276% from UK£1.78m profit in FY 2023).
  • UK£0.016 loss per share (down from UK£0.009 profit in FY 2023).
earnings-and-revenue-history
AIM:TLY Earnings and Revenue History July 30th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Totally Earnings Insights

Looking ahead, revenue is expected to decline by 6.1% p.a. on average during the next 2 years, while revenues in the Healthcare industry in the United Kingdom are expected to grow by 7.5%.

Performance of the British Healthcare industry.

The company's shares are down 6.0% from a week ago.

Risk Analysis

You should learn about the 2 warning signs we've spotted with Totally (including 1 which doesn't sit too well with us).

Valuation is complex, but we're here to simplify it.

Discover if Totally might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.